This phosphoramidite allows incorporation of an etheno bridged dG moiety internally or at the 5’ end of an oligonucleotide.
Allows the introduction of a 5-aminoallyl-deoxyuridine residue into oligonucleotides for the purpose of post-synthetic labeling by acylation.
Phosphoramidite used to incorporate an amino-modified dT into an oligonucleotide, with a 15-atom spacer.
Phosphoramidite used to incorporate a chloro-modified deoxycytidine internally or at the 5' end of an oligonucleotide.
A state-of-the-art cyclooctyne for catalyst free strain-promoted, copper-free azide-alkyne cycloadditions.
Phosphoramidite for the incorporation of a 2’-O-hexadecyl lipophilic chain-modified adenosine internally or at the 5' end of an oligonucleotide.
Phosphoramidite for the incorporation of a lipophilic dodecanoic chain internally or at the 5' end of an oligonucleotide, with a C7 spacer.
Phosphoramidite for the incorporation of a lipophilic palmitoyl-modifier internally or at the 5' end of an oligonucleotide, with a C7 spacer.
Phosphoramidite for the incorporation of a 2’-O-hexadecyl lipophilic chain-modified uracil internally or at the 5' end of an oligonucleotide.
Phosphoramidite for the incorporation of a 2’-O-hexadecyl lipophilic chain-modified cytidine internally or at the 5' end of an oligonucleotide.
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 1663 54600 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |
